BioCentury
ARTICLE | Company News

InVivo's Reynolds resigns, Vivus' Astrue interim CEO

August 22, 2013 11:25 PM UTC

Neurology company InVivo Therapeutics Holdings Corp. (OTCBB:NVIV) said Francis Reynolds resigned as chairman, CEO and CFO due to a medical condition. Michael Astrue, non-executive chairman at obesity company Vivus Inc. (NASDAQ:VVUS), is serving as interim CEO through Jan. 2014. Sean Moran, InVivo's director of finance, is acting CFO. Astrue joined Vivus last month as part of a settlement of a proxy battle between the biotech and activist investor First Manhattan Co. (see BioCentury Extra, July 23). ...